Page 15 - Edwin Coe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Countries like Italy are considering legal action against AstraZeneca to get delivery of their promised vaccine doses.

The row between the EU and AstraZeneca showed no sign of subsiding on Friday, even as the European commission published the terms of the deal struck between the two for millions of doses of the firm’s Covid-19 vaccine. The commission’s president, Ursula von der Leyen, said it was “crystal clear” that the contract required AstraZeneca to deliver doses produced in the UK to the EU to make up for a shortfall in orders. But the firm has said this is...

AstraZeneca Hit By Covid Jab Delays And Disagreements By V?ronique DUPONT 01/29/21 AT 10:35 PM Only a few weeks ago, Anglo-Swedish pharmaceutical giant AstraZeneca was being applauded for the speed with which it developed its Covid-19 vaccine. Experts heralded the launch of the jab as a turning point in the pandemic, not least because it can be transported and stored more easily than its Pfizer/BioNTech counterpart. The Anglo-Swedish firm also won plaudits for promising to provide the vaccine on a non-profit basis to lower- and middle-income countries. Now the vaccine has become a headach...

David Greene has not had the best of times as Law Society president — first the start of his one-year term at the helm of the body that represents 145,000 solicitors in England and Wales was delayed

Daniel Bellau Bellau, whose clients include entrepreneurs, SMEs, funds and AIM Nomads and Brokers, undertakes all aspects of corporate law, with particular experience in the real estate, TMT, hotel and leisure sectors. He also advises on equity capital markets transactions on the Official List and AIM. Head of corporate & commercial Russel Shear said: 'We are delighted to welcome Daniel to the firm. His background and wide-ranging experience makes him a perfect fit for the Corporate team, and for Edwin Coe as a whole. We are looking forward to working with him.' Bellau commented: 'I am very...